about
Atrial fibrillation: inflammation in disguise?Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke.Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery diseaseObesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Hypoadiponectinemia in patients with paroxysmal atrial fibrillationA polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsYKL-40--an emerging biomarker in cardiovascular disease and diabetes.YKL-40: a new biomarker in cardiovascular disease?Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.Plasma YKL-40 levels are elevated in patients with chronic heart failure.Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis
P2860
Q27693290-2F97785C-D330-4623-945B-4DB2BA73B51BQ34399182-594CBAD5-F0EF-40B2-BC5B-94569792F939Q34834538-ED310C53-8669-4460-B344-37642CB97B57Q36382360-6F4A3A22-01E5-4863-B105-68490963C6B2Q36385440-4595C8F9-B0C5-48A5-9A68-606E7747D31FQ36560782-ECD1ADEF-E63C-453B-8A73-468262D59DBCQ37334247-A77421C2-45F7-4D28-81CA-265369A8363CQ37496314-3697E1EB-3441-471C-BB49-BEE7EEB48E20Q37636543-6167E629-2CA4-4C3F-9277-2A985C5F0C76Q37779310-30D76F4B-5EBA-4F54-A12C-F4ACD183E258Q38915171-355B4A78-B930-423B-AAB6-7DBB250BE8CCQ40644091-7E8E1DC1-388D-4EDF-B7EA-9A28F1245AF7Q42241520-CCBA63F9-6AAF-4FF1-984C-051698462B9DQ43229804-0A12E137-4221-4354-9B50-1A6F42A892B3Q44510075-43778CD2-DC92-4F25-BA52-99108ABB8F3BQ48132620-01DF8CFE-9765-46FC-8375-F4ED3D9A9A5BQ51075335-1DAC418E-9D6C-4BE6-8FB8-3E1C62CBE032Q58778146-2E52A8CB-05FF-45F5-95DF-2E0242A7189B
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Plasma YKL-40, a new biomarker for atrial fibrillation?
@en
Plasma YKL-40, a new biomarker for atrial fibrillation?
@nl
type
label
Plasma YKL-40, a new biomarker for atrial fibrillation?
@en
Plasma YKL-40, a new biomarker for atrial fibrillation?
@nl
prefLabel
Plasma YKL-40, a new biomarker for atrial fibrillation?
@en
Plasma YKL-40, a new biomarker for atrial fibrillation?
@nl
P2093
P2860
P356
P1433
P1476
Plasma YKL-40, a new biomarker for atrial fibrillation?
@en
P2093
Helle Bruunsgaard
Julia Sidenius Johansen
Kristoffer Mads Henningsen
Susette Krohn Therkelsen
P2860
P304
P356
10.1093/EUROPACE/EUP103
P577
2009-05-02T00:00:00Z